Prot #BC-IMT-04: Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physician’s Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)

Project: Research project

Project Details

StatusActive
Effective start/end date12/12/2412/12/27

Funding

  • Numoda Technologies, Inc. (Prot #BC-IMT-04 // Prot #BC-IMT-04)
  • BriaCell Therapeutics Corp. [US] (Prot #BC-IMT-04 // Prot #BC-IMT-04)